Home > Income Statement > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Revenue

    Back to Income Statement
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Revenue History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹115 Cr₹85 Cr₹71 Cr₹42 Cr₹44 Cr

What is the latest Revenue of BAFNA PHARMACEUTICALS ?

The latest Revenue ratio of BAFNA PHARMACEUTICALS is ₹115 Cr based on Mar2024 Standalone results.
Year Revenue
Mar2024₹115 Cr
Mar2023₹85 Cr
Mar2022₹71 Cr
Mar2021₹42 Cr
Mar2020₹44 Cr

How is Revenue of BAFNA PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2024 ₹115 Cr
35.48
Mar2023 ₹85 Cr
19.55
Mar2022 ₹71 Cr
67.68
Mar2021 ₹42 Cr
-2.65
Mar2020 ₹44 Cr -

Compare Revenue of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹192.0 Cr 1.3% 1.3% -8.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,920.0 Cr -0.1% 1.7% 45.7% Stock Analytics
DIVIS LABORATORIES ₹155,160.0 Cr -0.1% -2.2% 56.9% Stock Analytics
CIPLA ₹118,917.0 Cr 1.7% 0.5% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹112,017.0 Cr 5.7% 12.4% 18.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,997.1 Cr -1.4% 3.1% 44.8% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

1.3%

1.3%

-8.9%

SENSEX

-5%

0.6%

9.2%


You may also like the below Video Courses